Morgan Stanley Knock-Out A2A/ DE000MG4NEV0 /
| 2024-07-26 8:39:46 PM | Chg.0.000 | Bid10:00:34 PM | Ask10:00:34 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.320EUR | 0.00% | - Bid Size: - |
- Ask Size: - |
A2A | 1.6582 EUR | 2078-12-31 | Call |
GlobeNewswire
05-10
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
05-06
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
03-19
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financ...
Newsfile Corp
03-08
Noda Presents Report on Key Payment Trends: Diverse PaymentMethods, AI, and More
GlobeNewswire
03-06
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
GlobeNewswire
2023-11-28
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update
GlobeNewswire
2023-11-07
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
GlobeNewswire
2023-11-07
iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
GlobeNewswire
2023-11-06
Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy...
Newsfile Corp
2023-10-04
Noda and Tickets Travel Network Forge Partnership for Seamless Travel Payments
GlobeNewswire
2023-09-21
Bluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice Preside...
GlobeNewswire
2023-09-20
Innovative Payment Solutions Announces Funding of Second $500,000 Capital Contribution to IPSIPay Ex...
GlobeNewswire
2023-09-05
Portage Biotech Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagon...
GlobeNewswire
2023-08-30
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business Update
GlobeNewswire
2022-03-10
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financ...
GlobeNewswire
2022-03-03
Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2021 Finan...
GlobeNewswire
2022-02-10
Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2021
GlobeNewswire
2022-02-02
Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer
GlobeNewswire
2022-01-14
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Initiated Phase 1/1b Clinical Trial o...
GlobeNewswire
2021-12-09
iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology...
GlobeNewswire
2021-11-12
Corvus Pharmaceuticals Presents Updated Data from Mupadolimab (Anti-CD73) Phase 1/1b Clinical Trial ...
GlobeNewswire
2021-11-10
Corvus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
